The document discusses current treatment options for low grade oligodendroglioma and the significance of 1p/19q loss of heterozygosity. It reviews evidence that surgical resection provides better outcomes than observation alone. Chemotherapy with procarbazine, lomustine, and vincristine or temozolomide is effective particularly for tumors with 1p/19q codeletion, while radiotherapy improves progression-free survival after incomplete resection but not overall survival. There is no consensus on the optimal treatment approach due to lack of prospective randomized controlled trials.